Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Many experts suggest that we're currently experiencing a renaissance in biotechnology. The field is undergoing revolutionary transformations, unlocking novel methods to combat...